{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:59:50Z","timestamp":1790866790940,"version":"4.1.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Since the first human implantation in 1980, implantable cardioverter-defibrillators (ICDs) have transformed the prevention of sudden cardiac death. Today, multiple ICD platforms are available, each with distinct strengths and limitations, making individualized device selection essential to optimize outcomes and minimize complications. The transvenous ICD remains the most established technology, offering reliable defibrillation, antitachycardia pacing (ATP), and pacing support, but is limited by lead-related complications and infection risk. The subcutaneous ICD avoids intravascular leads and is particularly attractive in younger patients and those at high risk of infection, although it lacks ATP and has shorter device longevity. The extravascular ICD is an emerging alternative designed to combine the advantages of both systems by providing ATP and shock therapy without intravascular leads, though implantation is more complex and long-term evidence remains limited. Given these differences, ICD selection should be guided by patient-specific clinical characteristics rather than a one-size-fits-all approach. Key determinants include pacing indication, prior lead failure, infection risk, body mass index, age, and arrhythmic substrate. The proposed clinical pathway offers a practical framework to support tailored ICD selection by integrating these variables into a structured decision-making process. Such an individualized approach may improve patient outcomes, reduce device-related complications, and enhance the appropriate adoption of contemporary ICD technologies.<\/jats:p>","DOI":"10.1093\/europace\/euag200","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T12:47:04Z","timestamp":1786798024000},"source":"Crossref","is-referenced-by-count":0,"title":["Beyond one-size-fits-all: personalized selection of contemporary implantable cardioverter-defibrillator therapies"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3617-2739","authenticated-orcid":false,"given":"Matteo","family":"Ziacchi","sequence":"first","affiliation":[{"name":"Institute of Cardiology, Cardio-Thoracic and Vascular Department, IRCCS Azienda Ospedaliero Universitaria di Bologna , Via Massarenti 9, Bologna 40138 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9820-4815","authenticated-orcid":false,"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[{"name":"Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4590-8584","authenticated-orcid":false,"given":"Mauro","family":"Biffi","sequence":"additional","affiliation":[{"name":"Institute of Cardiology, Cardio-Thoracic and Vascular Department, IRCCS Azienda Ospedaliero Universitaria di Bologna , Via Massarenti 9, Bologna 40138 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"2026100110361186300_euag200-B1","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"2026100110361186300_euag200-B2","doi-asserted-by":"crossref","first-page":"e1716","DOI":"10.1016\/j.hrthm.2026.04.015","article-title":"2026 HRS\/AHA\/APHRS\/EHRA\/IDSA\/LAHRS\/PACES\/STS expert consensus statement update on cardiovascular implantable electronic device lead management and extraction","volume":"23","author":"Cha","year":"2026","journal-title":"Heart Rhythm"},{"key":"2026100110361186300_euag200-B3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa0909545","article-title":"An entirely subcutaneous implantable cardioverter-defibrillator","volume":"363","author":"Bardy","year":"2010","journal-title":"N Engl J Med"},{"key":"2026100110361186300_euag200-B4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10840-018-0326-2","article-title":"Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic morphology tool","volume":"52","author":"Francia","year":"2018","journal-title":"J Interv Card Electrophysiol"},{"key":"2026100110361186300_euag200-B5","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/CIRCULATIONAHA.125.074576","article-title":"Device-related complications in transvenous versus subcutaneous defibrillator therapy during long-term follow-up: the PRAETORIAN-XL trial","volume":"152","author":"Olde Nordkamp","year":"2025","journal-title":"Circulation"},{"key":"2026100110361186300_euag200-B6","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/europace\/euad028","article-title":"Intermuscular technique for implantation of the subcutaneous implantable defibrillator: a propensity-matched case-control study","volume":"25","author":"Botto","year":"2023","journal-title":"Europace"},{"key":"2026100110361186300_euag200-B7","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf085.755","article-title":"The risk of failure of subcutaneous implantable cardioverter defibrillator therapy: from PRAETORIAN score to clinical practice","volume":"27","author":"Ziacchi","year":"2025","journal-title":"Europace"},{"key":"2026100110361186300_euag200-B8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/jce.14293","article-title":"Serratus anterior plane block in subcutaneous implantable cardioverter defibrillator implantation: a case-control analysis","volume":"31","author":"Ziacchi","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026100110361186300_euag200-B9","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCULATIONAHA.124.071795","article-title":"Performance and safety of the extravascular implantable cardioverter defibrillator through long-term follow-up: final results from the pivotal study","volume":"151","author":"Friedman","year":"2025","journal-title":"Circulation"},{"key":"2026100110361186300_euag200-B10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.hrthm.2025.02.012","article-title":"Periprocedural outcomes from the postmarket study of the extravascular implantable cardioverter-defibrillator: preliminary enlighten study results and meta-analysis","volume":"23","author":"Crozier","year":"2026","journal-title":"Heart Rhythm"},{"key":"2026100110361186300_euag200-B11","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf128","article-title":"The extravascular implantable defibrillator: a novel opportunity for the paediatric population","volume":"27","author":"Biffi","year":"2025","journal-title":"Europace"},{"key":"2026100110361186300_euag200-B12","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1016\/j.hrthm.2025.10.035","article-title":"Acute results of the ASCEND EV Study: a new modality of parasternal extravascular implantable cardioverter-defibrillator therapy including antitachycardia pacing","volume":"23","author":"Van der Stuijt","year":"2026","journal-title":"Heart Rhythm"},{"key":"2026100110361186300_euag200-B13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jelectrocard.2019.06.001","article-title":"Combination of a leadless pacemaker and subcutaneous defibrillator with nine effective shock treatments during follow-up of 18 months","volume":"56","author":"Ljungstr\u00f6m","year":"2019","journal-title":"J Electrocardiol"},{"key":"2026100110361186300_euag200-B14","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/jce.16570","article-title":"Predictors of right ventricular pacing in patients undergoing implantable defibrillator placement","volume":"36","author":"Hummel","year":"2025","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026100110361186300_euag200-B15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jacep.2021.08.009","article-title":"Risk factors for CIED infection after secondary procedures: insights from the WRAP-IT trial","volume":"8","author":"Tarakji","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"2026100110361186300_euag200-B16","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/jce.12035","article-title":"Left ventricular scar burden specifies the potential for ventricular arrhythmogenesis: an LGE-CMR study","volume":"24","author":"Scott","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026100110361186300_euag200-B17","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1016\/j.hrthm.2025.12.039","article-title":"Real-world performance of intrinsic antitachycardia pacing: primary results from a global prospective postapproval registry study","volume":"23","author":"Yee","year":"2026","journal-title":"Heart Rhythm"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/advance-article-pdf\/doi\/10.1093\/europace\/euag200\/70683499\/euag200.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/28\/10\/euag200\/70683499\/euag200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/28\/10\/euag200\/70683499\/euag200.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:41:15Z","timestamp":1790865675000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euag200\/8763637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euag200","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,8,18]]},"article-number":"euag200"}}